Clinical Trial Update: Fenretinide in Healthy Young Women at Genetic and Familial Risk [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for fenretinide in healthy young women at genetic/familial risk for cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Cancer

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: European Institute of Oncology | Conditions: High-Risk Cancer | Phase 3 | Status: TERMINATED